(DEMANT) Demant - Ratings and Ratios

Demant A/S is a leading global hearing healthcare company, operating across Europe, North America, Asia, the Pacific, and other international markets. The company specializes in the development, manufacturing, and distribution of advanced hearing aids and personalized hearing care products. Additionally, it offers comprehensive hearing and balance assessment solutions, which are utilized by audiologists, ENT specialists, and balance clinics. Demant A/S, formerly known as William Demant Holding A/S, rebranded in March 2019. Founded in 1904, it is headquartered in Smørum, Denmark. For more information, visit their website at https://www.demant.com.

Ticker Symbol: DEMANT
Exchange: CO
Type: Common Stock
Country Origin: Denmark
GICS Sub Industry: Health Care Equipment

Based on the provided data, here is a 3-month forecast:

Technical Outlook: The stock price of DEMANT is currently below its SMA 20 (232.69), SMA 50 (248.80), and SMA 200 (266.07), indicating a bearish trend. The ATR of 7.95 suggests moderate volatility, which could lead to a potential price range between 200-240 DKK over the next three months.

Fundamental Outlook: With a high RoE of 32.00% and a P/E ratio of 16.72, the company demonstrates strong profitability and reasonable valuation. The forward P/E of 16.00 and P/S of 2.11 suggest sustained growth potential, despite a high P/B of 4.95, indicating a premium valuation. This supports a bullish outlook for long-term investors, with expectations of the stock trading within the forecasted range.